-
公开(公告)号:US20050197347A1
公开(公告)日:2005-09-08
申请号:US11018489
申请日:2004-12-20
IPC分类号: A61K31/496 , C07D417/12 , C07D417/14
CPC分类号: C07D417/12
摘要: Provided is a crystalline form of ziprasidone base and processes for its preparation.
摘要翻译: 提供齐拉西酮碱的结晶形式及其制备方法。
-
公开(公告)号:US20080091019A1
公开(公告)日:2008-04-17
申请号:US11999369
申请日:2007-12-04
IPC分类号: C07D417/14
CPC分类号: C07D417/12
摘要: Provided is a crystalline form of ziprasidone base and processes for its preparation.
摘要翻译: 提供齐拉西酮碱的结晶形式及其制备方法。
-
公开(公告)号:US20080091018A1
公开(公告)日:2008-04-17
申请号:US11999339
申请日:2007-12-04
IPC分类号: C07D417/14
CPC分类号: C07D417/12
摘要: Provided is a crystalline form of ziprasidone base and processes for its preparation.
摘要翻译: 提供齐拉西酮碱的结晶形式及其制备方法。
-
公开(公告)号:US20080091017A1
公开(公告)日:2008-04-17
申请号:US11999294
申请日:2007-12-04
IPC分类号: C07D417/02
CPC分类号: C07D417/12
摘要: Provided is a crystalline form of ziprasidone base and processes for its preparation.
-
5.Polymorphic forms of ziprasidone HCI and processes for their preparation 审中-公开
标题翻译: 齐拉西酮HCl的多晶型及其制备方法公开(公告)号:US20080091020A1
公开(公告)日:2008-04-17
申请号:US11999453
申请日:2007-12-03
IPC分类号: C07D417/14
CPC分类号: C07D417/12 , A61K31/496
摘要: Provided are various polymorphic forms of ziprasidone HCl and processes for their preparation.
摘要翻译: 提供齐拉西酮HCl的各种多晶型物及其制备方法。
-
6.Polymorphic forms of ziprasidone HCI and processes for their preparation 审中-公开
标题翻译: 齐拉西酮HCl的多晶型及其制备方法公开(公告)号:US20050043324A1
公开(公告)日:2005-02-24
申请号:US10860926
申请日:2004-06-03
IPC分类号: A61K31/496 , A61P25/18 , C07D417/12 , A61K31/519
CPC分类号: C07D417/12 , A61K31/496
摘要: Provided are various polymorphic forms of ziprasidone HCl and processes for their preparation.
摘要翻译: 提供齐拉西酮HCl的各种多晶型物及其制备方法。
-
7.Polymorphic forms of ziprasidone HCl and processes for their preparation 审中-公开
标题翻译: 齐拉西酮HCl的多晶型形式及其制备方法公开(公告)号:US20080090835A1
公开(公告)日:2008-04-17
申请号:US11999337
申请日:2007-12-03
IPC分类号: A61K31/501 , A61P25/18 , C07D417/02
CPC分类号: C07D417/12 , A61K31/496
摘要: Provided are various polymorphic forms of ziprasidone HCl and processes for their preparation.
摘要翻译: 提供齐拉西酮HCl的各种多晶型物及其制备方法。
-
8.Processes for preparation of polymorphic form II of sertraline hydrochloride 审中-公开
标题翻译: 制备盐酸舍曲林多晶型II的方法公开(公告)号:US20070213404A1
公开(公告)日:2007-09-13
申请号:US11801663
申请日:2007-05-09
申请人: Ronen Borochovitch , Marioara Mendelovici , Tamar Nidam , Ruth Tenengauzer , Julia Hrakovsky , Judith Aronhime
发明人: Ronen Borochovitch , Marioara Mendelovici , Tamar Nidam , Ruth Tenengauzer , Julia Hrakovsky , Judith Aronhime
IPC分类号: A61K31/135 , C07C211/38
CPC分类号: C07C209/84 , C07C2602/10 , C07C211/42
摘要: Provided are processes for preparation of crystalline sertraline hydrochloride Form II substantilly free of other polymorphic forms of sertraline hydrochloride, preferably on an industrial scale.
摘要翻译: 提供制备结晶的舍曲林盐酸盐形式II的方法,其基本上不含其他多晶型的舍曲林盐酸盐,优选在工业规模上。
-
公开(公告)号:US06600073B1
公开(公告)日:2003-07-29
申请号:US09586842
申请日:2000-06-05
申请人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
发明人: Eduard Schwartz , Tamar Nidam , Anita Liberman , Marioara Mendelovici , Judith Aronhime , Claude Singer , Evgeni Valdman
IPC分类号: C07C21100
CPC分类号: C07C209/84 , A61K31/135 , C07C211/42 , C07C2602/10
摘要: Novel methods for the preparation of sertraline hydrochloride Forms III, V, VI, VII, VII, IX and X are disclosed. According to the present invention, sertraline hydrochloride Form III may be produced by heating sertraline hydrochloride Forms V and VI. Sertraline hydrochloride Forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X may be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.
摘要翻译: 公开了制备盐酸舍曲林的新方法,形式III,V,VI,VII,VII,IX和X。 根据本发明,盐酸舍曲林盐酸盐形式III可以通过加热盐酸舍曲林形式V和VI来制备。 盐酸舍曲林形式V和VI可以通过结晶从舍曲林盐酸盐或舍曲林碱产生。 盐酸舍曲林形式VII可以通过将舍曲林氯化物多晶型V悬浮在水中,然后过滤来制备。 盐酸舍曲林形式VIII和IX可以通过将舍曲林碱悬浮在水中然后酸化和过滤来制备。 舍曲林盐酸盐形式X可以通过在加热下将舍曲林盐酸舍曲林悬浮在苄醇中,然后过滤来制备。
-
10.Processes for preparation of polymorphic form II of sertraline hydrochloride 审中-公开
标题翻译: 制备盐酸舍曲林多晶型II的方法公开(公告)号:US20080161607A1
公开(公告)日:2008-07-03
申请号:US12074837
申请日:2008-03-05
申请人: Ronen Borochovitch , Marioara Mendelovici , Tamar Nidam , Ruth Tenengauzer , Julia Hrakovsky , Judith Aronhime
发明人: Ronen Borochovitch , Marioara Mendelovici , Tamar Nidam , Ruth Tenengauzer , Julia Hrakovsky , Judith Aronhime
IPC分类号: C07C211/45
CPC分类号: C07C209/84 , C07C2602/10 , C07C211/42
摘要: Provided are processes for preparation of crystalline sertraline hydrochloride Form II substantially free of other polymorphic forms of sertraline hydrochloride, preferably on an industrial scale.
摘要翻译: 提供了制备基本上不含其他多晶型盐酸舍曲林盐酸盐的结晶舍曲林盐酸盐形式II的方法,优选在工业规模上。
-
-
-
-
-
-
-
-
-